Austin HA, Boumpas DT, Vaughan EM, Balow JE: Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int. 1994, 45: 544-550. 10.1038/ki.1994.70.
Article
PubMed
Google Scholar
Bono L, Cameron JS, Hicks JA: The very long-term prognosis and complications of lupus nephritis and its treatment. QJM. 1999, 92: 211-218. 10.1093/qjmed/92.4.211.
Article
CAS
PubMed
Google Scholar
Berden JH: Lupus nephritis. Kidney Int. 1997, 52: 538-558. 10.1038/ki.1997.365.
Article
CAS
PubMed
Google Scholar
Manson JJ, Ma A, Rogers P, Mason LJ, Berden JH, van der Vlag J, D'Cruz DP, Isenberg DA, Rahman A: Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Arthritis Res Ther. 2009, 11: R154-10.1186/ar2831.
Article
PubMed Central
PubMed
Google Scholar
Sasaki T, Muryoi T, Hatakeyama A, Suzuki M, Sato H, Seino J, Saito T, Yoshinaga K: Circulating anti-DNA immune complexes in active lupus nephritis. Am J Med. 1991, 91: 355-362. 10.1016/0002-9343(91)90152-N.
Article
CAS
PubMed
Google Scholar
Qing X, Pitashny M, Thomas DB, Barrat FJ, Hogarth MP, Putterman C: Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury. Immunol Lett. 2008, 121: 61-73. 10.1016/j.imlet.2008.08.007.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bell CW, Jiang W, Reich CF, Pisetsky DS: The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol. 2006, 291: C1318-C1325. 10.1152/ajpcell.00616.2005.
Article
CAS
PubMed
Google Scholar
Landsman D, Bustin M: A signature for the HMG-1 box DNA-binding proteins. Bioessays. 1993, 15: 539-546. 10.1002/bies.950150807.
Article
CAS
PubMed
Google Scholar
Wang H, Vishnubhakat JM, Bloom O, Zhang M, Ombrellino M, Sama A, Tracey KJ: Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery. 1999, 126: 389-392. 10.1016/S0039-6060(99)70182-0.
Article
CAS
PubMed
Google Scholar
Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, Rubartelli A: The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 2002, 3: 995-1001. 10.1093/embo-reports/kvf198.
Article
PubMed Central
CAS
PubMed
Google Scholar
Harris HE, Raucci A: Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep. 2006, 7: 774-778.
PubMed Central
CAS
PubMed
Google Scholar
Kokkola R, Andersson A, Mullins G, Ostberg T, Treutiger CJ, Arnold B, Nawroth P, Andersson U, Harris RA, Harris HE: RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol. 2005, 61: 1-9. 10.1111/j.0300-9475.2005.01534.x.
Article
CAS
PubMed
Google Scholar
Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, Hua J, An LL, Audoly L, La Rosa G, Bierhaus A, Naworth P, Marshak-Rothstein A, Crow MK, Fitzgerald KA, Latz E, Kiener PA, Coyle AJ: Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007, 8: 487-496.
Article
CAS
PubMed
Google Scholar
Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ, Tracey KJ, Yang H: HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock. 2006, 26: 174-179. 10.1097/01.shk.0000225404.51320.82.
Article
CAS
PubMed
Google Scholar
Abdulahad DA, Westra J, Bijzet J, Limburg PC, Kallenberg CG, Bijl M: High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Arthritis Res Ther. 2011, 13: R71-10.1186/ar3332.
Article
PubMed Central
PubMed
Google Scholar
Hayashi A, Nagafuchi H, Ito I, Hirota K, Yoshida M, Ozaki S: Lupus antibodies to the HMGB1 chromosomal protein: epitope mapping and association with disease activity. Mod Rheumatol. 2009, 19: 283-292. 10.1007/s10165-009-0151-7.
Article
CAS
PubMed
Google Scholar
Li J, Xie H, Wen T, Liu H, Zhu W, Chen X: Expression of High Mobility Group Box Chromosomal Protein 1 and Its Modulating Effects on Downstream Cytokines in Systemic Lupus Erythematosus. J Rheumatol. 2010, 37: 766-775. 10.3899/jrheum.090663.
Article
CAS
PubMed
Google Scholar
Casciola-Rosen LA, Anhalt G, Rosen A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med. 1994, 179: 1317-1330. 10.1084/jem.179.4.1317.
Article
CAS
PubMed
Google Scholar
Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M: The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004, 15: 241-250. 10.1097/01.ASN.0000108969.21691.5D.
Article
PubMed
Google Scholar
Bruchfeld A, Qureshi AR, Lindholm B, Barany P, Yang L, Stenvinkel P, Tracey KJ: High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD). Mol Med. 2008, 14: 109-115. 10.1007/s00894-007-0256-x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bruchfeld A, Wendt M, Bratt J, Qureshi AR, Chavan S, Tracey KJ, Palmblad K, Gunnarsson I: High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations. Mol Med. 2011, 17: 29-35.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kim J, Sohn E, Kim CS, Jo K, Kim JS: The role of high-mobility group box-1 protein in the development of diabetic nephropathy. Am J Nephrol. 2011, 33: 524-529. 10.1159/000327992.
Article
CAS
PubMed
Google Scholar
Ma CY, Jiao YL, Zhang J, Yang QR, Zhang ZF, Shen YJ, Chen ZJ, Zhao YR: Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus. Rheumatol Int. 2012, 32: 395-402. 10.1007/s00296-010-1636-6.
Article
CAS
PubMed
Google Scholar
Oyama Y, Hashiguchi T, Taniguchi N, Tancharoen S, Uchimura T, Biswas KK, Kawahara K, Nitanda T, Umekita Y, Lotz M, Maruyama I: High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy. Lab Invest. 2010, 90: 853-866. 10.1038/labinvest.2010.64.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sato F, Maruyama S, Hayashi H, Sakamoto I, Yamada S, Uchimura T, Morita Y, Ito Y, Yuzawa Y, Maruyama I, Matsuo S: High mobility group box chromosomal protein 1 in patients with renal diseases. Nephron Clin Pract. 2008, 108: c194-c201. 10.1159/000118942.
Article
CAS
PubMed
Google Scholar
Zickert A, Palmblad K, Sundelin B, Chavan S, Tracey KJ, Bruchfeld A, Gunnarsson I: Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis. Arthritis Res Ther. 2012, 14: R36-10.1186/ar3747.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wada Y, Ito S, Ueno M, Nakano M, Arakawa M, Gejyo F: Renal outcome and predictors of clinical renal involvement in patients with silent lupus nephritis. Nephron Clin Pract. 2004, 98: c105-111. 10.1159/000081551.
Article
PubMed
Google Scholar
Mao SY, Xu Y, Zhang J, Schifferli K, An LL, Leininger J, Kiener P, Wu H, Coyle AJ, Audoly LP: Antagonizing HMGB1 inhibits proteinuria in a murine model of lupus like disease. (abstract). J Immunol. 2008, 178: 131-124.
Google Scholar